This study provides new insights into therapeutic strategies for inflammatory lung diseases, highlighting FBLN1 as a promising therapeutic target to prevent ARDS via controlling important proteins that participate in oxidative stress and ferroptosis pathways. Here, FBLN1 is linked to acute respiratory distress syndrome.